medigraphic.com
ISSN 2448-8011 (Electronic)
Revista de Divulgación del INSTITUTO DE MEDICINA FORENSE de la UNIVERSIDAD VERACRUZANA

2022, Number 1

<< Back Next >>

Rev Mex Med Forense 2022; 7 (1)

Detection, collection and packaging of cocaine in medical expertise

Perezcampos MC, Martínez HR, Pérez CE, Hernández GM, Marín MV

Language: Spanish
References: 42
Page: 103-124
PDF size: 341.12 Kb.


ABSTRACT

Cocaine is an alkaloid and a powerful stimulant of natural origin, extracted from the leaves of the coca plant (Erythroxylum coca). In the human body it acts as an indirect adrenergic agonist, that is, it produces effects similar to sympathomimetics.


REFERENCES

  1. Ackerman, J. P., Riggins, T., & Black, M. M. (2010). A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics, 125(3), 554-565.

  2. Álvaro Perrote, C. (2015). Métodos de determinación de cocaína ilícita en presencia de adulterantes.

  3. Ballou, S. M., Kline, M. C., Stolorow, M. D., Taylor, M. K., Williams, S. R., Bamberger, P. S., ... & Ostrom, B. (2013). The biological evidence preservation handbook: best practices for evidence handlers.

  4. Barajas-Calderón, HI; García-Hinojosa, CA; Salas-Cruz, VA (2020). Toxicología forense. Red Internacional de Divulgación Científica Forense. Recuperado en 02 de junio de 2020, de https://drive.google.com/file/d/1GinDr_spknrTLS36B pcmABaph-8OEing/view

  5. Bolla, K. I., Cadet, J. L., & London, E. D. (1998). The neuropsychiatry of chronic cocaine abuse. The Journal of Neuropsychiatry and Clinical Neurosciences, 10(3), 280-289.

  6. Brodie, M. S., & Dunwiddie, T. V. (1990). Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action. Naunyn-Schmiedeberg's archives of pharmacology, 342(6), 660-665.

  7. Casale, J. F., & Klein, R. F. X. (1993). Illicit production of cocaine. Forensic Science Review, 5, 95-95.

  8. Del Bosque, J., Mairena, A. F., Díaz, D. B., Espínola, M., García, N. G., Abdalá, A. L., ... & Vázquez, L. (2014). La cocaína: consumo y consecuencias. Salud mental, 37(5), 381-389.

  9. Garro Vargas, K. (2011). Cocaína: actualización médico legal. Medicina Legal de Costa Rica, 28(2), 57-62.

  10. Gossop, M., Griffiths, P., Powis, B., & Strang, J. (1992). Severity of dependence and route of administration of heroin, cocaine and amphetamines. British journal of addiction, 87(11), 1527-1536.

  11. Hawthorne, M. R. (1998). First unit responder: A guide to physical evidence collection for patrol officers. CRC Press.

  12. Hayes, J., & Fox, K. (2021). Urine drug screening: A guide to monitoring Tx with controlled substances. THE JOURNAL OF FAMILY PRACTICE, 70(3).

  13. Heard, K., Palmer, R., & Zahniser, N. R. (2008). Mechanisms of acute cocaine toxicity. The open pharmacology journal, 2(9), 70.

  14. Hoffman, R. S., Henry, G. C., Howland, M. A., Weisman, R. S., Weil, L., & Goldfrank, L. R. (1992). Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Annals of emergency medicine, 21(3), 247-253.

  15. Huttunen, J., Austin, C., Dawson, M., Roux, C., & Robertson, J. (2007). Physical evidence in drug intelligence, Part 1: rationale based on hierarchic distribution of drugs using pyrolysis gas chromatography–mass spectrometry as an example. Australian Journal of Forensic Sciences, 39(2), 93-106.

  16. Grogger, J., & Willis, M. (2000). The emergence of crack cocaine and the rise in urban crime rates. Review of Economics and Statistics, 82(4), 519-529.

  17. Jatlow, P. (1988). Cocaine: analysis, pharmacokinetics, and metabolic disposition. The Yale journal of biology and medicine, 61(2), 105.

  18. Kerridge, B. T., Chou, S. P., Pickering, R. P., Ruan, W. J., Huang, B., Jung, J., ... & Hasin, D. S. (2019). Changes in the prevalence and correlates of cocaine use and cocaine use disorder in the United States, 2001–2002 and 2012–2013. Addictive behaviors, 90, 250-257.

  19. Lee, H. C., & Ladd, C. (2001). Preservation and collection of biological evidence. Croatian medical journal, 42(3), 225-228.

  20. Lee, H. C., & Pagliaro, E. M. (2013). Forensic evidence and crime scene investigation. Journal of Forensic Investigation, 1(2), 1-5.

  21. Lizasoain, I., Moro, M. A., & Lorenzo, P. (2001). Cocaine: Pharmacologia Aspects. Adicciones, 13(2).

  22. Lizasoain, I., Moro, M. A., & Lorenzo, P. (2002). Cocaína: aspectos farmacológicos. Adicciones, 14(1), 57-64.

  23. Madden, J. A., & Powers, R. H. (1990). Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life sciences, 47(13), 1109-1114.

  24. Mayes, L. C. (1996). Exposure to cocaine: Behavioral outcomes in preschool and school-age children. Behavioral studies of drug-exposed offspring: methodological issues in human and animal research. NIDA Research Monograph, (164), 211-29.

  25. Morton, W. A. (1999). Cocaine and psychiatric symptoms. Primary care companion to the Journal of clinical psychiatry, 1(4), 109.

  26. Pérez Alfonso, C. M. (2017). Determinación de cocaína por espectrometría vibracional.

  27. Ramos, J. C., Luna, A. E. V., & Lima, C. M. O. (2013). Espectroscopia Raman y sus aplicaciones. Opt. Pura. Apl, 83-95.

  28. Rao, P. K., Pandey, G., & Tharmavaram, M. (2020). Biological Evidence and Their Handling. Technology in Forensic Science: Sampling, Analysis, Data and Regulations, 35-53.

  29. Regenjo Vázquez, M. (2020). Evaluación de la presencia de psicofármacos y drogas de abuso en muestras biológicas y ambientales mediante nuevas metodologías analíticas.

  30. Ryan, S. A. (2019). Cocaine Use in Adolescents and Young Adults. Pediatric Clinics, 66(6), 1135-1147.

  31. Sánchez Thevenet, P., & Haro Cortés, G. R. (2017). Evaluación del consumo de cannabis, cocaína y alcohol en trabajadores del sector del espectáculo y eficacia de una intervención motivacional breve de enfermería/tesis doctoral presentada por Isabel Almodóvar Fernández; dirigida por [la] Dra. Dña. Paula Sánchez Thevenet y el Dr. D. Gonzalo Rafael Haro Cortés.

  32. Singh, S. (2000). Chemistry, design, and structure− activity relationship of cocaine antagonists. Chemical reviews, 100(3), 925-1024.

  33. Tazelaar, H. D., Karch, S. B., Stephens, B. G., & Billingham, M. E. (1987). Cocaine and the heart. Human pathology, 18(2), 195-199.

  34. Teeters, W. R., Koppanyi, T., & Cowan, F. F. (1963). Cocaine tachyphylaxis. Life Sciences, 2(7), 509-518.

  35. Tortajada Navarro, S. (2008). Cocaína y conductas violentas. Un estudio cualitativo desde una perspectiva de género.

  36. Touroo, R., & Fitch, A. (2018). Crime Scene Findings and the Identification, Collection, and Preservation of Evidence. In Veterinary Forensic Pathology, Volume 1 (pp. 9-25). Springer, Cham.

  37. UNODC. Métodos recomendados para la identificación y el análisis de cocaína en materiales incautados. Viena, Austria: United Nations publication; 2020.

  38. UVCLIN, M. D. L. C. (2020). Manual Toma y Transporte de Muestras del Laboratorio Clínico (Doctoral dissertation, Universidad de Valparaíso).

  39. Villanueva, J., & Zelaya, M. M. (2016). Ciencias Forenses y Pruebas Presuntivas. Suicidio por arma blanca Muerte súbita del adulto de origen cardiovascular, 45.

  40. Vongpatanasin, W., Mansour, Y., Chavoshan, B., Arbique, D., & Victor, R. G. (1999). Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation, 100(5), 497-502.

  41. Washton, A. M., & Gold, M. S. (1984). Chronic cocaine abuse: Evidence for adverse effects on health and functioning.

  42. Washton, A. M., & Stone-Washton, N. (1990). Outpatient treatment of cocaine addiction: suggestions to increase its effectiveness. International journal of the addictions, 25(sup12), 1421-1429.




2020     |     www.medigraphic.com